Changes in maternal age and prevalence of congenital anomalies during the enactment of China's universal two-child policy (2013–2017) in Zhejiang Province, China: An observational study
Autoři:
Xiaohui Zhang aff001; Lijin Chen aff001; Xuemiao Wang aff001; Xiaoyan Wang aff001; Menghan Jia aff001; Saili Ni aff001; Wei He aff004; Shankuan Zhu aff001
Působiště autorů:
Chronic Disease Research Institute, School of Public Health, and Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
aff001; Department of Nutrition and Food Hygiene, School of Public Health, Zhejiang University, Hangzhou, Zhejiang, China
aff002; Department of Women’s Health, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
aff003; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
aff004
Vyšlo v časopise:
Changes in maternal age and prevalence of congenital anomalies during the enactment of China's universal two-child policy (2013–2017) in Zhejiang Province, China: An observational study. PLoS Med 17(2): e32767. doi:10.1371/journal.pmed.1003047
Kategorie:
Research Article
doi:
https://doi.org/10.1371/journal.pmed.1003047
Souhrn
Background
China implemented a partial two-child policy (2013) followed by a universal two-child policy (2015), replacing the former one-child policy mandated by the government. The changes affect many aspects of China’s population as well as maternal and infant health, but their potential impact on birth defects (BDs) remains unknown. In this study, we investigated the associations of these policy changes with BDs in Zhejiang Province, China.
Methods and findings
We used data from the BD surveillance system in Zhejiang Province, China, which covers 90 hospitals in 30 urban districts and rural counties, capturing one-third of the total births in this province. To fully consider the time interval between conception and delivery, we defined the one-child policy period as data from 2013 (births from October 2012 to September 2013), the partial two-child policy period as data from 2015 (births from October 2014 to September 2015), and the universal two-child policy period as data from 2017 (births from October 2016 to September 2017). Data from 2009 and 2011 were also used to show the changes in the proportion of births to women with advanced maternal age (35 years and older) prior to the policy changes. Main outcome measures were changes in the proportion of mothers with advanced maternal age, prevalence of BDs, rankings of BD subtypes by prevalence, prenatal diagnosis rate, and live birth rate of BDs over time. A total of 1,260,684 births (including live births, early fetal losses, stillbirths, and early neonatal deaths) were included in the analyses. Of these, 644,973 (51.16%) births were to women from urban areas, and 615,711 (48.84%) births were to women from rural areas. In total, 135,543 (10.75%) births were to women with advanced maternal age. The proportion increased by 85.68%, from 8.52% in 2013 to 15.82% in 2017. However, it had remained stable prior to policy changes. Overall, 23,095 BDs were identified over the policy changes (2013–2017). The prevalence of BDs during 2013, 2015, and 2017 was 245.95, 264.86, and 304.36 per 10,000 births, respectively. Trisomy 21 and other chromosomal defects increased in both risk and ranking from 2013 to 2017 (crude odds ratio [95% confidence interval] 2.13 [1.75–2.60], from ranking 10th to 5th, and 3.63 [2.84–4.69], from ranking 16th to 6th, respectively). The prenatal diagnosis rate increased by 3.63 (2.2–5.1) percentage points (P < 0.001), from 31.10% to 34.72%, and identification of BDs occurred 1.88 (1.81–1.95) weeks earlier (P < 0.001). The live birth rate for infants with BDs born before 28 gestational weeks increased from 1.29% to 11.45%. The major limitations of this observational study include an inability to establish causality and the possible existence of unknown confounding factors, some of which could contribute to BDs.
Conclusions
In this study, we observed significant increases in maternal age and the prevalence of total and age-related anomalies following China’s new two-child policy. Increases in live birth rate for infants with BDs born before 28 gestational weeks suggest that healthcare for very preterm births with BDs may be warranted in the future, as well as updating the definition of perinatal period.
Klíčová slova:
Birth – Birth defects – Cleft lip – Cleft lip and palate – Cleft palate – Congenital anomalies – Infants – Labor and delivery
Zdroje
1. National Bureau of Statistics of China [Internet]. Beijing: National Bureau of Statistics of China; 2019 [cited 2019 Oct 8]. Available from: http://data.stats.gov.cn/english/.
2. Jiang Q, Li S, Feldman MW. China’s Population Policy at the Crossroads: Social Impacts and Prospects. Asian J Soc Sci. 2013;41: 193–218. doi: 10.1163/15685314-12341298 26612983
3. Feng W, Gu B, Cai Y. The End of China’s One-Child Policy. Stud Fam Plann. 2016;47: 83–86. doi: 10.1111/j.1728-4465.2016.00052.x 27027994
4. Zeng Y, Hesketh T. The effects of China’s universal two-child policy. Lancet. 2016;388: 1930–1938. doi: 10.1016/S0140-6736(16)31405-2 27751400
5. 2016 National Economic and Social Development Statistical Bulletin of the People's Republic of China [Internet]. Beijing: National Bureau of Statistics of China; 2017 [cited 2020 Feb 6]. Available from: http://www.stats.gov.cn/tjsj/zxfb/201702/t20170228_1467424.html.
6. Schwank SE, Gu C, Cao Z, Andersson E, Jiang H, Ding Y, et al. China’s child policy shift and its impact on Shanghai and Hangzhou women’s decision-making. Int J Womens Health. 2018;10: 639–648. doi: 10.2147/IJWH.S172804 30498373
7. Zhao J, Shan N, Yang X, Li Q, Xia Y, Zhang H, et al. Effect of second child intent on delivery mode after Chinese two child policy implementation: a cross sectional and prospective observational study of nulliparous women in Chongqing. BMJ Open. 2017;7: e018823. doi: 10.1136/bmjopen-2017-018823 29282269
8. Wang E, Hesketh T. Large reductions in cesarean delivery rates in China: a qualitative study on delivery decision-making in the era of the two-child policy. BMC Pregnancy Childbirth. 2017;17: 405. doi: 10.1186/s12884-017-1597-9 29202726
9. Zhang H-X, Zhao Y-Y, Wang Y-Q. Analysis of the Characteristics of Pregnancy and Delivery before and after Implementation of the Two-child Policy. Chin Med J (Engl). 2018;131: 37–42. doi: 10.4103/0366-6999.221268 29271378
10. Zeng C, Yang M, Ding Y, Duan S, Zhou Y. Placenta accreta spectrum disorder trends in the context of the universal two-child policy in China and the risk of hysterectomy. Int J Gynaecol Obstet. 2018;140: 312–318. doi: 10.1002/ijgo.12418 29214633
11. Liang J, Mu Y, Li X, Tang W, Wang Y, Liu Z, et al. Relaxation of the one child policy and trends in caesarean section rates and birth outcomes in China between 2012 and 2016: observational study of nearly seven million health facility births. BMJ. 2018;360: k817. doi: 10.1136/bmj.k817 29506980
12. Yang M, Fan X-B, Wu J-N, Wang J-M. Association of assisted reproductive technology and multiple pregnancies with the risks of birth defects and stillbirth: A retrospective cohort study. Sci Rep. 2018;8: 8296. doi: 10.1038/s41598-018-26567-2 29844441
13. McNeese ML, Selwyn BJ, Duong H, Canfield M, Waller DK. The association between maternal parity and birth defects. Birth Defects Res A Clin Mol Teratol. 2015;103: 144–156. doi: 10.1002/bdra.23360 25721953
14. Ameen SK, Alalaf SK, Shabila NP. Pattern of congenital anomalies at birth and their correlations with maternal characteristics in the maternity teaching hospital, Erbil city, Iraq. BMC Pregnancy Childbirth. 2018;18: 501. doi: 10.1186/s12884-018-2141-2 30563491
15. Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199: 237.e1–237.e9. doi: 10.1016/j.ajog.2008.06.028 18674752
16. Christianson A, Howson CP, Modell B. March of Dimes global report on birth defects. White Plains, New York: March of Dimes Birth Defects Foundation; 2006 [cited 2019 Jan 22]. Available from: http://www.marchofdimes.com/downloads/Birth_Defects_Report-PF.pdf.
17. Centers for Disease Control and Prevention [Internet]. Data & Statistics on Birth Defects. Atlanta: Centers for Disease Control and Prevention; 2018 Apr 30 [cited 2019 Jan 10]. Available from: https://www.cdc.gov/ncbddd/birthdefects/data.html.
18. European Commission [Internet]. Cases and prevalence (per 10,000 births) for all full member registries from 2012 to 2016. EUROCAT. European Commission; 2019 [cited 2019 Jan 10]. Available from: http://www.eurocat-network.eu/accessprevalencedata/prevalencetables
19. Bairoliya N, Fink G. Causes of death and infant mortality rates among full-term births in the United States between 2010 and 2012: An observational study. PLoS Med. 2018;15: e1002531. doi: 10.1371/journal.pmed.1002531 29558463
20. Ko HS, Kim DJ, Chung Y, Wie JH, Choi SK, Park IY, et al. A national cohort study evaluating infant and fetal mortality caused by birth defects in Korea. BMJ Open. 2017;7: e017963. doi: 10.1136/bmjopen-2017-017963 29146644
21. Liang J, Li X, Kang C, Wang Y, Kulikoff XR, Coates MM, et al. Maternal mortality ratios in 2852 Chinese counties, 1996–2015, and achievement of Millennium Development Goal 5 in China: a subnational analysis of the Global Burden of Disease Study 2016. Lancet. 2019;393: 241–252. doi: 10.1016/S0140-6736(18)31712-4 30554785
22. China’s Ministry of Health. Prenatal Care Regulation. Jun 23, 2011 [cited 2019 Mar 4]. Available from: http://www.nhc.gov.cn.
23. International Statistical Classification of Diseases and Related Health Problems 10th Revision [Internet]. In: ICD-10 Version:2016. Geneva: World Health Organization; [cited 2019 Mar 4]. Available from: https://icd.who.int/browse10/2016/en#/XVII.
24. Zhu J, Liang J, Mu Y, Li X, Guo S, Scherpbier R, et al. Sociodemographic and obstetric characteristics of stillbirths in China: a census of nearly 4 million health facility births between 2012 and 2014. Lancet Glob Health. 2016;4: e109–118. doi: 10.1016/S2214-109X(15)00271-5 26795603
25. Xie X, Gou W, Lin Z, Di W, Ma D, Kong B. Prenatal Examination and Antenatal Care. Obstetrics and Gynecology. 8th ed. Beijing: People’s Health Publishing House; 2013. p. 142.
26. Behboudi-Gandevani S, Ziaei S, Farahani FK, Jasper M. The Perspectives of Iranian Women on Delayed Childbearing: A Qualitative Study. J Nurs Res. 2015;23: 313–321. doi: 10.1097/JNR.0000000000000084 26562463
27. Goisis A, Sigle-Rushton W. Childbearing Postponement and Child Well-being: A Complex and Varied Relationship? Demography. 2014;51: 1821–1841. doi: 10.1007/s13524-014-0335-4 25316169
28. Xie D, Yang T, Liu Z, Wang H. Epidemiology of Birth Defects Based on a Birth Defect Surveillance System from 2005 to 2014 in Hunan Province, China. PLoS ONE. 2016;11: e0147280. doi: 10.1371/journal.pone.0147280 26812057
29. Morris JK, Springett AL, Greenlees R, Loane M, Addor M-C, Arriola L, et al. Trends in congenital anomalies in Europe from 1980 to 2012. PLoS ONE. 2018;13: e0194986. doi: 10.1371/journal.pone.0194986 29621304
30. Postoev VA, Nieboer E, Grjibovski AM, Odland JØ. Prevalence of birth defects in an Arctic Russian setting from 1973 to 2011: a register-based study. Reprod Health. 2015;12: 3. doi: 10.1186/1742-4755-12-3 25577202
31. Ko J-K, Lamichhane DK, Kim H-C, Leem J-H. Trends in the Prevalences of Selected Birth Defects in Korea (2008–2014). Int J Environ Res Public Health. 2018;15: 923. doi: 10.3390/ijerph15050923 29734759
32. Pangkanon S, Sawasdivorn S, Kuptanon C, Chotigeat U, Vandepitte W. Establishing of National Birth Defects Registry in Thailand. J Med Assoc Thai. 2014;97 Suppl 6: S182–8.
33. Bhide P, Gund P, Kar A. Prevalence of Congenital Anomalies in an Indian Maternal Cohort: Healthcare, Prevention, and Surveillance Implications. PLoS ONE. 2016;11: e0166408. doi: 10.1371/journal.pone.0166408 27832123
34. Wu L, Li B, Xia J, Ji C, Liang Z, Ma Y, et al. Prevalence of congenital heart defect in Guangdong province, 2008–2012. BMC Public Health. 2014;14: 152. doi: 10.1186/1471-2458-14-152 24517105
35. Leirgul E, Fomina T, Brodwall K, Greve G, Holmstrøm H, Vollset SE, et al. Birth prevalence of congenital heart defects in Norway 1994–2009—A nationwide study. Am Heart J. 2014;168: 956–964. doi: 10.1016/j.ahj.2014.07.030 25458661
36. Egbe A, Uppu S, Lee S, Stroustrup A, Ho D, Srivastava S. Temporal Variation of Birth Prevalence of Congenital Heart Disease in the United States. Congenit Heart Dis. 2015;10: 43–50. doi: 10.1111/chd.12176 24612877
37. Zhang X-H, Qiu L-Q, Ye Y-H, Xu J. Chromosomal abnormalities: subgroup analysis by maternal age and perinatal features in zhejiang province of China, 2011–2015. Ital J Pediatr. 2017;43. doi: 10.1186/s13052-017-0363-y 28499441
38. Maxwell S, Bower C, O’Leary P. Impact of prenatal screening and diagnostic testing on trends in Down syndrome births and terminations in Western Australia 1980 to 2013. Prenat Diagn. 2015;35: 1324–1330. doi: 10.1002/pd.4698 26411476
39. Loane M, Morris JK, Addor M-C, Arriola L, Budd J, Doray B, et al. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet. 2013;21: 27–33. doi: 10.1038/ejhg.2012.94 22713804
40. Deng C, Yi L, Mu Y, Zhu J, Qin Y, Fan X, et al. Recent trends in the birth prevalence of Down syndrome in China: impact of prenatal diagnosis and subsequent terminations. Prenat Diagn. 2015;35: 311–318. doi: 10.1002/pd.4516 25315427
41. Goldberg MF. Reducing Birth Defect Risk in Advanced Maternal Age. JAMA. 1979;242: 2292–2294. doi: 10.1001/jama.1979.03300210018013 490824
42. Department of Maternal and Child Health [Internet]. Circular of the General Office of the State Health and Family Planning Commission on standardizing and orderly Prenatal screening and diagnosis of Fetal Free DNA in Peripheral Blood of pregnant Women. Beijing: Department of Maternal and Child Health; 2016 [cited 2019 May 9]. Available from: http://www.nhc.gov.cn/fys/s3581/201611/0e6fe5bac1664ebda8bc28ad0ed68389.shtml?from=groupmessage&isappinstalled=0.
43. Brender J, Suarez L, Hendricks K, Baetz RA, Larsen R. Parental Occupation and Neural Tube Defect-Affected Pregnancies Among Mexican Americans. J Occup Environ Med. 2002;44: 650–656. doi: 10.1097/00043764-200207000-00011 12138876
44. Zhang X-H, Qiu L-Q, Huang J-P. Risk of birth defects increased in multiple births. Birth Defects Res A Clin Mol Teratol. 2011;91: 34–38. doi: 10.1002/bdra.20725 20890935
45. Castillo-Lancellotti C, Tur JA, Uauy R. Impact of folic acid fortification of flour on neural tube defects: a systematic review. Public Health Nutr. 2013;16: 901–911. doi: 10.1017/S1368980012003576 22850218
46. Khoshnood B, Loane M, de Walle H, Arriola L, Addor M-C, Barisic I, et al. Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ. 2015;351: h5949. doi: 10.1136/bmj.h5949 26601850
47. Zhang T-N, Gong T-T, Chen Y-L, Wu Q-J, Zhang Y, Jiang C-Z, et al. Time trends in the prevalence and epidemiological characteristics of neural tube defects in Liaoning Province, China, 2006–2015: A population-based study. Oncotarget. 2017;8: 17092–17104. doi: 10.18632/oncotarget.15060 28177882
48. Department of Maternal and Child Health [Internet]. Circular of the Ministry of Finance of the State population and Family Planning Commission on promoting the full coverage of the National Free Pre-pregnancy Health examination Project. Beijing: Department of Maternal and Child Health; 2013 [cited 2019 Jan 10]. Available from: http://www.nhc.gov.cn/fys/s3589/201307/0ca30a6cbe7146fba86b0bf9211be576.shtml.
49. Department of Maternal and Child Health [Internet]. The project of newborn screening in poor area in 2013, China. Beijing: Department of Maternal and Child Health; 2013 [cited 2019 Dec 2]. Available from: http://www.nhc.gov.cn/fys/s3585/201311/4ce5a095f552423d82fcd0738cc13102.shtml.
50. Zheng J, Lu X, Liu H, Zhao P, Li K, Li L. MTHFD1 polymorphism as maternal risk for neural tube defects: a meta-analysis. Neurol Sci. 2015;36: 607–616. doi: 10.1007/s10072-014-2035-7 25502174
51. Desrosiers TA, Siega-Riz AM, Mosley BS, Meyer RE, National Birth Defects Prevention Study. Low carbohydrate diets may increase risk of neural tube defects. Birth Defects Res. 2018;110: 901–909. doi: 10.1002/bdr2.1198 29368448
52. World Health Organization [Internet]. Maternal and perinatal health. Geneva, Switzerland: World Health Organization; [cited 2019 Jan 28]. Available from: https://www.who.int/maternal_child_adolescent/topics/maternal/maternal_perinatal/en/.
53. Jin L, Jin L, Yu J, Xu Y, Liu H, Ren A. Prevalence of Neural Tube Defects and the Impact of Prenatal Diagnosis in Three Districts of Beijing, China. Paediatr Perinat Epidemiol. 2017;31: 293–300. doi: 10.1111/ppe.12354 28464249
54. Pei L, Kang Y, Zhao Y, Yan H. Prevalence and risk factors of congenital heart defects among live births: a population-based cross-sectional survey in Shaanxi province, Northwestern China. BMC Pediatr. 2017;17: 18. doi: 10.1186/s12887-017-0784-1 28086762
55. Zhao W, Chen F, Wu M, Jiang S, Wu B, Luo H, et al. Postnatal Identification of Trisomy 21: An Overview of 7,133 Postnatal Trisomy 21 Cases Identified in a Diagnostic Reference Laboratory in China. PLoS ONE. 2015;10: e0133151. doi: 10.1371/journal.pone.0133151 26176847
56. Zhang Y, Zhou Y, Li H, Gao Y, Zhang Y, Luo S, et al. Secular trends of institutional delivery rate in China from 1996 to 2015. Natl Med J China. 2017;97: 1337–1342. doi: 10.3760/cma.j.issn.0376-2491.2017.17.014 28482438
Článek vyšel v časopise
PLOS Medicine
2020 Číslo 2
- Distribuce a lokalizace speciálně upravených exosomů může zefektivnit léčbu svalových dystrofií
- O krok blíže k pochopení efektu placeba při léčbě bolesti
- Prof. Jan Škrha: Metformin je bezpečný, ale je třeba jej bezpečně užívat a léčbu kontrolovat
- FDA varuje před selfmonitoringem cukru pomocí chytrých hodinek. Jak je to v Česku?
- Vánoční dárky s přidanou hodnotou pro zdraví – nechte se inspirovat a poraďte svým pacientům
Nejčtenější v tomto čísle
- Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study
- Digitally enabled aged care and neurological rehabilitation to enhance outcomes with Activity and MObility UsiNg Technology (AMOUNT) in Australia: A randomised controlled trial
- The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial
- An evaluation of Chile’s Law of Food Labeling and Advertising on sugar-sweetened beverage purchases from 2015 to 2017: A before-and-after study